Detalhe da pesquisa
1.
Incidence of SARS-CoV-2 infection in patients with multiple sclerosis who received SARS-CoV-2 vaccines and are under treatment with high-efficacy therapies in Argentina.
Neurol Sci
; 45(2): 379-389, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38159147
2.
Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world setting.
Mult Scler
; 29(10): 1240-1249, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37491849
3.
Argentinean consensus recommendations for the use of telemedicine in clinical practice in adult people with multiple sclerosis.
Neurol Sci
; 44(2): 667-676, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36319902
4.
Disability outcomes in NMOSD and MOGAD patients: data from a nationwide registry in Argentina.
Neurol Sci
; 44(1): 281-286, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36166174
5.
Clinical and demographic characteristics of primary progressive multiple sclerosis in Argentina: Argentinean registry cohort study (RelevarEM).
Neurol Sci
; 41(11): 3329-3335, 2020 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-32840711
6.
Multiple sclerosis and neuromyelitis optica spectrum disorders in Argentina: comparing baseline data from the Argentinean MS Registry (RelevarEM).
Neurol Sci
; 41(6): 1513-1519, 2020 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-31960250
7.
Correction to: Argentinean consensus recommendations for the use of telemedicine in clinical practice in adult people with multiple sclerosis.
Neurol Sci
; 44(3): 1135, 2023 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-36348171
8.
Correction to: Clinical and demographic characteristics of primary progressive multiple sclerosis in Argentina: Argentinean registry cohort study (RelevarEM).
Neurol Sci
; 42(12): 5441, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-34557969
9.
Burden of treatment and quality of life in relapsing remitting multiple sclerosis patients under early high efficacy therapy in Argentina: Data from the Argentinean registry.
Mult Scler Relat Disord
; 85: 105543, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38520948
10.
Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in Argentina.
Clin Neuropharmacol
; 2024 May 23.
Artigo
Inglês
| MEDLINE | ID: mdl-38776535
11.
Treatment strategies and responses for attacks of neuromyelitis optica spectrum disorder: A real-world retrospective cohort study.
J Neurol Sci
; 462: 123099, 2024 Jun 14.
Artigo
Inglês
| MEDLINE | ID: mdl-38897155
12.
Occurrence of area postrema syndrome during follow-up: phenotype and influence over NMOSD activity in LATAM in real-world settings.
J Neurol
; 2024 Apr 17.
Artigo
Inglês
| MEDLINE | ID: mdl-38630312
13.
Selection of disease modifying therapies in multiple sclerosis based on patient's age and disease activity: Data from a nationwide registry.
J Neurol Sci
; 461: 123052, 2024 Jun 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38797140
14.
Shared decision making in the treatment of multiple sclerosis: A consensus based on Delphi methodology.
Mult Scler Relat Disord
; 70: 104465, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36565557
15.
Barriers to access and unmet needs to neuromyelitis optica spectrum disorders care in an Argentinean cohort.
Mult Scler Relat Disord
; 70: 104485, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36610362
16.
Mortality of neuromyelitis optica spectrum disorder patients in an Argentinean population: A study from the RelevarEM registry.
Mult Scler J Exp Transl Clin
; 9(4): 20552173231205444, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37854639
17.
Accumulative risk of clinical event in high-risk radiologically isolated syndrome in Argentina: data from the nationwide registry RelevarEM.
J Neurol
; 269(4): 2073-2079, 2022 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-34491406
18.
Seasonal variation in attacks of neuromyelitis optica spectrum disorders and multiple sclerosis: Evaluation of 794 attacks from a nationwide registry in Argentina.
Mult Scler Relat Disord
; 58: 103466, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-34929456
19.
Clinical and demographic characteristics of male MS patients included in the national registry-RelevarEM. Does sex or phenotype make the difference in the association with poor prognosis?
Mult Scler Relat Disord
; 58: 103401, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-35216784
20.
Incidence of COVID-19 after vaccination in people with multiple sclerosis in Argentina: Data from the nationwide registry RelevarEM.
Mult Scler Relat Disord
; 68: 104104, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36057175